Skip to content
OpenCapital
Get started

Zimmer Biomet Holdings ZBH Q1 2025 earnings

Reported May 5, 2025 · Before market open

Revenue$1.9BBeat by $13.9MDiluted EPS$1.81Beat by $0.04
Revenue estimate$1.9B
EPS estimate$1.77

Next report

Aug 6, 2026 (In 3 weeks)
Revenue estimate$2.1B
EPS estimate$2.01

Financials

Q1 2025

Income statement

See full
Revenue$1.9B+1.1%
Gross profit$1.4B-1.3%
Operating income$292.3M+9.9%
Net income$182.0M+5.6%
EPS (diluted)$0.91+8.3%

Balance sheet

See full
Cash & equivalents$1.4B+252%
Total debt$7.2B+23.8%
Total equity$12.4B-1.6%
Total assets$22.2B+3.4%

Cash flow

See full
Operating cash flow$382.8M+67.9%
CapEx$44.6M-19.1%
Free cash flow$338.2M+95.6%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$22.53B-18.2%
Enterprise value$28.32B-14.0%
P/E24.7×-3.9×
P/S2.9×-0.8×

Profitability

See full
Gross margin71.1%-0.8pp
Operating margin17%+0.7pp
Net margin11.9%-1.1pp
FCF margin19%+2.8pp

Returns & leverage

See full
Return on equity7.3%-0.5pp
Debt / equity0.6×+0.1×
Current ratio2.4×+0.8×

Segments

By product

See full
Knees$792.9M+0.6%
Hips$495.8M+0.9%
SET$470.5M+4.0%
Technology And Data Bone Cement And Surgical$149.9M-4.7%

By geography

See full
Americas$1.2B+1.7%
EMEA$441.7M-0.7%
Asia Pacific$260.5M+1.0%

Versus estimates

Revenue

Q1 2026$2.1BBeat by $16.2MQ4 2025$2.2BBeat by $19.9MQ3 2025$2.0BMiss by $10.4MQ2 2025$2.1BBeat by $20.5M
Q1 2025$1.9BBeat by $13.9M
Q4 2024$2.0BBeat by $8.9M

Diluted EPS

Q1 2026$2.09Beat by $0.23Q4 2025$2.42Beat by $0.04Q3 2025$1.90Beat by $0.03Q2 2025$2.07Beat by $0.09
Q1 2025$1.81Beat by $0.04
Q4 2024$2.31Beat by $0.01

Ask the moment Zimmer Biomet Holdings reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Zimmer Biomet Holdings report Q1 2025 earnings?
Zimmer Biomet Holdings (ZBH) reported Q1 2025 earnings on May 5, 2025 before market open.
What were Zimmer Biomet Holdings's Q1 2025 revenue and EPS?
Zimmer Biomet Holdings reported revenue of $1.9B and diluted EPS of $1.81 for Q1 2025.
Did Zimmer Biomet Holdings beat estimates in Q1 2025?
Revenue beat the consensus estimate of $1.9B by $13.9M. EPS beat the consensus estimate of $1.77 by $0.04.
How did Zimmer Biomet Holdings's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1.1% from $1.9B a year earlier and diluted EPS declined 6.7% from $1.94.
Where can I find Zimmer Biomet Holdings's Q1 2025 SEC filings?
You can read the 10-Q periodic report (0000950170-25-063509) directly on SEC EDGAR. The filing index links above go to sec.gov.